Advertisement
Screener

908 DEVICES INC. (MASS) Net Income

908 DEVICES INC. Net Income

908 DEVICES INC. (MASS) reported Net Income of -$11.89 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.

Financial Statements › Income Statement › Net Income

us-gaap:NetIncomeLoss · last filed 2026-08-11

  • 908 DEVICES INC. net income (loss) attributable to parent for the quarter ending 2026-06-30 was -$11.89M.
  • 908 DEVICES INC. net income (loss) attributable to parent for the quarter ending 2026-03-31 was -$11.96M, a 127.42% decline year-over-year.
  • 908 DEVICES INC. net income (loss) attributable to parent for the quarter ending 2025-12-31 was $4.17M.
  • 908 DEVICES INC. net income (loss) attributable to parent for the quarter ending 2025-09-30 was -$14.98M.
  • 908 DEVICES INC. net income (loss) attributable to parent for fiscal 2023 was -$36.40M.
  • 908 DEVICES INC. net income (loss) attributable to parent for fiscal 2022 was -$33.56M.
  • 908 DEVICES INC. net income (loss) attributable to parent for fiscal 2021 was -$22.17M.
  • 908 DEVICES INC. net income (loss) attributable to parent for fiscal 2020 was -$12.82M.
Period endNet Income (Loss) Attributable to Parent 3 monthNet Income (Loss) Attributable to Parent 6 monthNet Income (Loss) Attributable to Parent 9 monthNet Income (Loss) Attributable to Parent 12 monthNet Income (Loss) Attributable to Parent 12 month as first filed
2026-06-30-$11.89M
10-Q · filed 2026-08-11
-$23.85M
10-Q · filed 2026-08-11
-$19.68M
derived: sum of 3 quarters · filed 2026-08-11
-$34.66M
derived: sum of 4 quarters · filed 2026-08-11
2026-03-31-$11.96M
10-Q · filed 2026-08-11
-$7.78M
derived: sum of 2 quarters · filed 2026-08-11
-$22.76M
derived: sum of 3 quarters · filed 2026-08-11
-$36.07M
derived: sum of 4 quarters · filed 2026-08-11
2025-12-31$4.17M
derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-29
-$10.81M
derived: sum of 2 quarters · filed 2026-04-29
-$24.11M
derived: sum of 3 quarters · filed 2026-08-11
$19.49M
DEF 14A · filed 2026-04-29
2025-09-30-$14.98M
10-Q · filed 2025-11-10
-$28.29M
derived: sum of 2 quarters · filed 2026-08-11
$15.31M
10-Q · filed 2025-11-10
-$4.13M
derived: sum of 4 quarters · filed 2026-08-11
2025-06-30-$13.31M
10-Q · filed 2026-08-11
$30.30M
10-Q · filed 2026-08-11
$10.85M
derived: sum of 3 quarters · filed 2026-08-11
-$18.44M
derived: sum of 4 quarters · filed 2026-08-11
2025-03-31$43.60M
10-Q · filed 2026-08-11
$24.16M
derived: sum of 2 quarters · filed 2026-08-11
-$5.14M
derived: sum of 3 quarters · filed 2026-08-11
-$17.69M
derived: sum of 4 quarters · filed 2026-08-11
2024-12-31-$19.45M
derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-29
-$48.74M
derived: sum of 2 quarters · filed 2026-04-29
-$61.29M
derived: sum of 3 quarters · filed 2026-04-29
-$72.21M
DEF 14A · filed 2026-04-29
2024-09-30-$29.30M
10-Q · filed 2025-11-10
-$41.84M
derived: sum of 2 quarters · filed 2025-11-10
-$52.76M
10-Q · filed 2025-11-10
-$60.19M
derived: sum of 4 quarters · filed 2025-11-10
2024-06-30-$12.55M
10-Q · filed 2025-11-10
-$23.46M
10-Q · filed 2025-08-05
-$30.89M
derived: sum of 3 quarters · filed 2025-11-10
-$37.99M
derived: sum of 4 quarters · filed 2025-11-10
2024-03-31-$10.92M
10-Q · filed 2025-11-10
-$18.35M
derived: sum of 2 quarters · filed 2025-11-10
-$25.44M
derived: sum of 3 quarters · filed 2025-11-10
-$34.78M
derived: sum of 4 quarters · filed 2025-11-10
2023-12-31-$7.43M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07
-$14.52M
derived: sum of 2 quarters · filed 2025-03-07
-$23.87M
derived: sum of 3 quarters · filed 2025-03-07
-$36.40M
10-K · filed 2025-03-07
2023-09-30-$7.09M
10-Q · filed 2024-11-12
-$16.44M
derived: sum of 2 quarters · filed 2024-11-12
-$28.97M
10-Q · filed 2024-11-12
-$38.76M
derived: sum of 4 quarters · filed 2024-11-12
2023-06-30-$9.35M
10-Q · filed 2024-11-12
-$21.88M
10-Q · filed 2024-08-06
-$31.67M
derived: sum of 3 quarters · filed 2024-11-12
-$37.93M
derived: sum of 4 quarters · filed 2024-11-12
2023-03-31-$12.53M
10-Q · filed 2024-11-12
-$22.32M
derived: sum of 2 quarters · filed 2024-11-12
-$28.58M
derived: sum of 3 quarters · filed 2024-11-12
-$36.68M
derived: sum of 4 quarters · filed 2024-11-12
2022-12-31-$9.79M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08
-$16.05M
derived: sum of 2 quarters · filed 2024-03-08
-$24.15M
derived: sum of 3 quarters · filed 2024-03-08
-$33.56M
10-K · filed 2024-03-08
2022-09-30-$6.26M
10-Q · filed 2023-11-07
-$14.36M
derived: sum of 2 quarters · filed 2023-11-07
-$23.77M
10-Q · filed 2023-11-07
-$27.24M
derived: sum of 4 quarters · filed 2023-11-07
2022-06-30-$8.10M
10-Q · filed 2023-11-07
-$17.51M
10-Q · filed 2023-08-08
-$20.98M
derived: sum of 3 quarters · filed 2023-11-07
-$26.16M
derived: sum of 4 quarters · filed 2023-11-07
2022-03-31-$9.41M
10-Q · filed 2023-11-07
-$12.88M
derived: sum of 2 quarters · filed 2023-11-07
-$18.07M
derived: sum of 3 quarters · filed 2023-11-07
-$25.49M
derived: sum of 4 quarters · filed 2023-11-07
2021-12-31-$3.46M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15
-$8.65M
derived: sum of 2 quarters · filed 2023-03-15
-$16.07M
derived: sum of 3 quarters · filed 2023-03-15
-$22.17M
10-K · filed 2023-03-15
2021-09-30-$5.18M
10-Q · filed 2022-11-14
-$12.61M
derived: sum of 2 quarters · filed 2022-11-14
-$18.70M
10-Q · filed 2022-11-14
-$28.93M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30-$7.42M
10-Q · filed 2022-11-14
-$13.52M
10-Q · filed 2022-08-09
-$23.75M
derived: sum of 3 quarters · filed 2022-11-14
-$25.47M
derived: sum of 4 quarters · filed 2022-11-14
2021-03-31-$6.09M
10-Q · filed 2022-11-14
-$16.32M
derived: sum of 2 quarters · filed 2022-11-14
-$18.04M
derived: sum of 3 quarters · filed 2022-11-14
-$15.95M
derived: sum of 4 quarters · filed 2022-11-14
2020-12-31-$10.23M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11
-$11.95M
derived: sum of 2 quarters · filed 2022-03-11
-$9.85M
derived: sum of 3 quarters · filed 2022-03-11
-$12.82M
10-K · filed 2022-03-11
$12.80M
10-Q · filed 2021-05-13
2020-09-30-$1.72M
10-Q · filed 2021-11-04
$373.00K
derived: sum of 2 quarters · filed 2021-11-04
-$2.59M
10-Q · filed 2021-11-04
2020-06-30$2.10M
10-Q · filed 2021-11-04
-$871.00K
10-Q · filed 2021-08-04
2020-03-31-$2.97M
10-Q · filed 2021-11-04

Similar stocks

Stock NameCountryMarket CapPE Ratio
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
EyePoint, Inc. (EYPT)United States$0.314B-3.96
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15
Quanterix Corp (QTRX)United States$0.150B-1.65
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Seer, Inc. (SEER)United States$0.104B-1.34
Precipio, Inc. (PRPO)United States$0.043B-36.70
HARVARD BIOSCIENCE INC (HBIO)United States$0.037B-2.70
Bionano Genomics, Inc. (BNGO)United States$0.020B-0.42
ASTROTECH Corp (ASTC)United States$0.013B